These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 9036311)

  • 21. [Perioperative Bridging with Enoxaparin. Results of the Prospective BRAVE Registry with 779 Patients].
    Omran H; Hammerstingl C; Paar WD;
    Med Klin (Munich); 2007 Oct; 102(10):809-15. PubMed ID: 17928964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of venous thromboembolism in the acute treatment phase after spinal cord injury: a randomized, multicenter trial comparing low-dose heparin plus intermittent pneumatic compression with enoxaparin.
    Spinal Cord Injury Thromboprophylaxis Investigators
    J Trauma; 2003 Jun; 54(6):1116-24; discussion 1125-6. PubMed ID: 12813332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of low molecular weight heparin in total knee arthroplasty.
    Iobst CA; Friedman RJ
    Am J Knee Surg; 1999; 12(1):55-60. PubMed ID: 10050695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Venous thromboembolism prophylaxis conversion in nonsurgical inpatients.
    Carroll DN; Hudson EB
    Ann Pharmacother; 2003 Sep; 37(9):1194-6. PubMed ID: 12921498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interpretation of benefit-risk of enoxaparin as comparator in the RECORD program: rivaroxaban oral tablets (10 milligrams) for use in prophylaxis in deep vein thrombosis and pulmonary embolism in patients undergoing hip or knee replacement surgery.
    Van Thiel D; Kalodiki E; Wahi R; Litinas E; Haque W; Rao G
    Clin Appl Thromb Hemost; 2009; 15(4):389-94. PubMed ID: 19608550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-molecular weight heparin as prophylaxis against thromboembolism after total hip replacement--is it worth the price?
    Persson BM
    Acta Orthop Scand; 2000 Apr; 71(2):215-6. PubMed ID: 10852334
    [No Abstract]   [Full Text] [Related]  

  • 27. Venous thromboembolism prophylaxis: role of factor xa inhibition by fondaparinux.
    Turpie AG
    Surg Technol Int; 2004; 13():261-7. PubMed ID: 15744699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.
    Stellbrink C; Nixdorff U; Hofmann T; Lehmacher W; Daniel WG; Hanrath P; Geller C; Mügge A; Sehnert W; Schmidt-Lucke C; Schmidt-Lucke JA;
    Circulation; 2004 Mar; 109(8):997-1003. PubMed ID: 14967716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Thromboembolic complications during total hip replacement arthroplasty (240 cases)].
    Pidhorz L; Raimbeau G; Galland F
    Agressologie; 1983 Nov; 24(10):519-21. PubMed ID: 6670680
    [No Abstract]   [Full Text] [Related]  

  • 30. Outpatient use of low-molecular weight heparin in an anticoagulated patient requiring oral surgery: case report.
    Todd DW; Roman A
    J Oral Maxillofac Surg; 2001 Sep; 59(9):1090-2; discussion 1092-3. PubMed ID: 11526584
    [No Abstract]   [Full Text] [Related]  

  • 31. Managing the risk of thrombosis in the perioperative period in patients undergoing orthopedic and trauma surgery with low-molecular-weight heparin: enoxaparin.
    Lassen MR; Borris LC
    Orthopedics; 1997 Feb; 20 Suppl():14-7. PubMed ID: 9048402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thromboprophylaxis and death after total hip replacement.
    Ranstam J; Swierstra BA
    J Bone Joint Surg Br; 1997 Sep; 79(5):880. PubMed ID: 9331062
    [No Abstract]   [Full Text] [Related]  

  • 33. Thromboprophylaxis and death after total hip replacement.
    Port AM; Stothard J
    J Bone Joint Surg Br; 1997 Sep; 79(5):879-80. PubMed ID: 9331061
    [No Abstract]   [Full Text] [Related]  

  • 34. FDA approves first generic enoxaparin product.
    Thompson CA
    Am J Health Syst Pharm; 2010 Sep; 67(18):1486, 1488. PubMed ID: 20811018
    [No Abstract]   [Full Text] [Related]  

  • 35. Prophylaxis for venous thromboembolism in total hip arthroplasty.
    Lyne E
    Orthopedics; 1991 Mar; 14(3):226-7, 230-1. PubMed ID: 2064678
    [No Abstract]   [Full Text] [Related]  

  • 36. [Prevention of embolism in severely ill internal medicine patients. In heart failure it is better to use low molecular weight heparin].
    MMW Fortschr Med; 1999 Nov; 141(46):64. PubMed ID: 10795156
    [No Abstract]   [Full Text] [Related]  

  • 37. Idrabiotaparinux treatment for venous thromboembolism.
    Eikelboom JW; Weitz JI
    Lancet; 2012 Jan; 379(9811):96-8. PubMed ID: 22127297
    [No Abstract]   [Full Text] [Related]  

  • 38. Medicine wastage in a thromboprophylaxis protocol for ambulatory trauma patients.
    Mower S; Thompson S
    Emerg Nurse; 2020 Nov; 28(6):35-40. PubMed ID: 32783433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of venous thromboembolism in high-risk patients by prophylactic administration of oral anticoagulants.
    Salzman EW
    Adv Exp Med Biol; 1987; 214():165-74. PubMed ID: 3310537
    [No Abstract]   [Full Text] [Related]  

  • 40. Thromboprophylaxis and death after total hip replacement.
    McNally MA
    J Bone Joint Surg Br; 1997 Sep; 79(5):878-9. PubMed ID: 9331060
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.